# EyeFree Assisting Communication

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/eyefree-assisting-communication

- Industry: Medical Devices & Equipment
- Headquarters: Tel Aviv-Yafo, Israel
- Website: www.eyecontrol.co.il
- Total disclosed funding: $10M
- Latest round: Series A (Aug 12, 2020)
- Investors on record: 3

## About

EyeFree Assisting Communication Ltd. specializes in innovative communication solutions for patients. Their products enhance communication in critical care settings, particularly for those with severe mobility limitations.Founded in 2016, EyeFree Assisting Communication Ltd. is headquartered in Tel Aviv-Yafo, Israel. The company offers advanced communication platforms for ICU and home care settings, focusing on patients who are unable to communicate due to medical conditions. The firm was founded by Itai Kornberg and Or Retzkin, and Or Retzkin currently serves as CEO. EyeFree has raised a total of USD 10.00 mn across four deals, with the latest funding being a Series A round of USD 10.00 mn on August 12, 2020, led by Connecticut Innovations, alongside participation from Benslie Investment Group and other investors.EyeControl's primary offerings include two advanced communication platforms: EyeControl-Med and EyeControl-Home. EyeControl-Med is an AI-driven patient engagement platform tailored for ICU environments, using a lightweight headset with infrared tracking technology that enables patients to communicate even during sedation. It incorporates a bone-conduction earpiece for clear audio, supporting both ICU patients and their families. EyeControl-Home facilitates ongoing communication for individuals transitioning from medical facilities to home care, addressing long-term deficits typical in conditions like locked-in syndrome. These products target healthcare providers in North America and Europe, aiming to improve patient engagement and communication.EyeControl generates revenue through a mix of direct sales and subscription models tailored for healthcare institutions. The company collaborates with hospitals to provide EyeControl-Med and EyeControl-Home, which are offered on a subscription basis inclusive of support and updates. Pricing is customized based on implementation scale, with institutional contracts enhancing revenue stability and supporting improved patient outcomes in critical care environments.Following the Series A funding round in August 2020, EyeFree Assisting Communication Ltd. aims to accelerate product development and expansion into new markets. The funds will be used to enhance existing products and introduce new solutions that meet patient needs. The company is focused on entering additional European and North American markets by late 2022, thereby increasing accessibility of their communication platforms for diverse healthcare providers.

## Funding rounds

- Series A, Aug 12, 2020, $10M — Connecticut Innovations, Benslie Investment Group
- Seed, Oct 1, 2017 — ZORA Ventures

## Investors

- ZORA Ventures (https://capitalatlas.ai/funds/zora-ventures) — Seed
- Connecticut Innovations (https://capitalatlas.ai/funds/connecticut-innovations) — Series A
- Benslie Investment Group — Series A